|
|
||||||||
Departments of Nuclear Medicine, Radiology and Gynecology, University of Bonn, Bonn, Germany
Correspondence: For correspondence or reprints contact: Olaf Rieker, MD, Clinic for Nuclear Medicine, University of Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany.
ABSTRACT
Bone scintigraphy of a 40-yr-old patient suffering from primary breast cancer suggested the possibility of diffuse metastases. Bone marrow scintigraphy using 99mTc-labeled monoclonal antibodies (BW 250/183) demonstrated diffuse destruction of bone marrow due to metastatic disease and consecutive bone marrow extension. Bone marrow scintigraphy was highly sensitive in detecting progression of disease in this asymptomatic patient.
Key Words: bone marrow scintigraphy repeat immunoscans disseminated metastases follow-up
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |